Risk Register
Risk Register — C.E. Info Systems Ltd (MAPMYINDIA)
Risk Dashboard
MapMyIndia has 9 active risks requiring immediate monitoring, of which 4 are high-impact and 2 are critical. The investment case is binary: rests entirely on whether the Q4 FY26 results (due May 15, 2026, days away) deliver the promised 35%+ operating margin and confirm order book conversion. Without that, the bear's structural demand-erosion thesis becomes the default. The single highest-priority tripwire is Q4 FY26 map-led revenue growth, which will show whether government timing delays are truly one-time or reflect permanent competitive or structural loss.
Active Risks
Critical or High Impact
Critical Impact Only
Overall risk posture: HIGH — Q4 FY26 order book conversion is the single decisive test.
Risk Distribution (Probability × Impact)
The Active Risk Register
All risks sourced from upstream report agents. No new risks invented; every risk cites evidence from Stan (Verdict), Forensics, Historian (Story), Moat, Competition, Catalysts, or Business analysis. Dormant risks appear in the register if they carry High or Critical impact even if unlikely to crystallise in 12 months.
Top 5 Risks — What Would Break This Investment
1. Order Book Conversion Fails — Q4 FY26 Test (Probability: High | Impact: Critical)
The ₹1,770 Cr order book is the single fact preventing a collapse of the bull case. For three consecutive quarters, revenue contracted while the order book grew — the only argument that kept conviction alive. Q4 FY26 results arriving May 15, 2026 will answer the question directly: can the company convert its highest-seasonality quarter into revenue that clears ₹100 Cr map-led run-rate (matching Q4 FY25) at 35%+ operating margin? The forensics are clean: the company has no liquidity or solvency stress that would warrant a margin of safety below full execution. The risk is pure execution and timing. If Q4 FY26 map-led revenue is flat or negative year-over-year, or if operating margin falls below 35% despite peak seasonality, the "disbursement timing" hypothesis collapses and the bear's demand-erosion narrative becomes default. Mitigation: the order book is real (confirmed in investor calls, not management hallucination), government clients have committed funding, and Q4's historical 30-50% seasonal lift is built on multi-year precedent. Residual risk: even if Q4 beats expectations, FY27 H1 must show sustained map revenue growth — a single strong quarter followed by H1 decay would signal cyclical timing offset structural decline. The market reaction to a Q4 miss would be sharp (stock likely tests ₹800 range within 30 days); a beat would create room for a ₹1,200-1,300 re-rating toward analyst consensus targets.
Q4 FY26 results in 3 days (May 15, 2026). The stock surged +12.6% on May 11 positioning for a beat. A miss triggers a sharp re-test of 52-week lows; a beat creates a genuine re-entry setup.
2. Ola Maps Enterprise Competition Erodes Pricing Power (Probability: Medium | Impact: Critical)
The map-led segment's 46.5% EBITDA margin has held steady for three years through commentary about rising competition. That margin is the only empirical proof that the moat works. Ola Maps — built by ANI Technologies, using OpenStreetMap base data, Indian-owned (no regulatory barrier), and priced aggressively for enterprise APIs — has not yet visibly converted MapMyIndia enterprise customers, but the risk is not that one customer converts; the risk is that the pricing anchor shifts downward and customers begin evaluating Ola's improving quality at 30-40% lower pricing. The forensic evidence: TomTom's moat collapse (from €701M revenue FY2019 to €555M FY2025) happened precisely because HERE and Google pricing pressure eroded the customer lock-in once alternative products reached functional parity. MapMyIndia has three structural advantages TomTom lacked: regulatory barrier (20% of revenue locked via India's "Owned in India" mandate), OEM recertification cycles (18-24 month lock-in), and a 30-year data corpus on Indian hyper-local geography. But enterprise APIs (40% of segment revenue per the Q3 FY26 presentation) have no 18-month recertification cycle; switching takes 6-12 months, making them the weakest link in the moat. Mitigation: 100% OEM retention is genuine switching-cost evidence; government segment grows as regulatory wall hardens. Residual risk: if Ola Maps captures 5%+ of the 5,000+ enterprise customer base in 9M FY27–9M FY28, or if one major customer (PhonePe, Amazon Alexa, Uber) visibly tests an alternate provider, the margin sustainability story deteriorates and multiple compression follows. The Q4 FY26 earnings call will be the first real-time window to hear management's Ola Maps competitive assessment.
Ola Maps is the one competitor that structurally threatens all four moat pillars simultaneously. It has regulatory access (unlike Google/TomTom), Indian ownership, price advantage, and is growing aggressively into the enterprise developer community.
3. Guidance Miss Pattern Persists — Q4 FY26 Is Third Consecutive Disappointment (Probability: High | Impact: High)
MapMyIndia has missed six of eight major guidance commitments since IPO: the QIP ₹500 Cr never deployed, FY27-28 ₹1,000 Cr target was pushed to FY28, IoT 10× growth never delivered, B2C ad-revenue assumptions required spinoff to hide, CAGR guidance never materialized. Management's credibility with consensus analysts is binary: Q4 FY26 will be graded on one metric: did the company deliver what it explicitly committed to? In Q3 FY26 earnings call, management stated it "stands behind" the 35% FY26 EBITDA margin guidance despite 9M tracking at 33.7%. The math is clean: Q4 must deliver 40%+ operating margin to hit 35% full-year. That is seasonally achievable (Q4 is peak-government-collection quarter), but it requires near-perfect execution. If Q4 operating margin is 32-34% (missing the 35% target by 1-3 percentage points), the market will interpret it as the third consecutive guidance miss on the core margin story and will mark the company as "deliver on commitments only when everything breaks right, not reliably." This cascades to the ₹1,000 Cr FY28 target, which now requires 40%+ CAGR from a FY26 base of ~₹490 Cr — the exact execution bar that Q4 will test. Mitigation: management has been transparent about the specific headwinds (Maharashtra/Bihar election moratoriums, fiscal grant delays to Q4) and has not revised the target. The one-time cost charges in Q2-Q3 have a credible paper trail. Residual risk: one more guidance miss (even by 2-3%), combined with investor fatigue, will collapse institutional conviction below a level from which recovery is slow. The stock would likely trade in a ₹850-1,000 range for 12+ months until FY27 full-year results validate recovery.
4. Receivables Quality Deteriorates — DSO Spike Becomes Provision Event (Probability: Medium | Impact: High)
Debtor days rose from 76 (FY2023) to 101 (FY2024) to 105 (FY2025) — a 38% jump without corresponding commentary in the MD&A or annual report. The rise coincides with government segment growth (now ~20% of revenue), which structurally has longer payment cycles. But the magnitude is concerning: implied FY2024 receivables grew 79% against 35% revenue growth, a classic receivables-pressure signal. The forensic flag is not fraud — the company's cash pile grew from ₹381 Cr (FY2022) to ₹643 Cr (Q3 FY26), independently validating the profitability claims. But the cash generation is weaker than reported earnings suggest (3-year FCF/NI = 0.47x), and receivables accumulation is a material mechanism. The specific risk: if government clients (IOCL, Survey of India, state agencies) face fiscal stress or delayed central disbursements, receivables could stretch to 120+ days or require a specific provision. This would not signal accounting manipulation but rather a real cash-flow pressure from business-mix shift. Mitigation: large government contracts (IOCL ₹110 Cr, Survey of India NAKSHA) are disclosed and are high-probability payers; no evidence of disputed contracts; promoter has zero pledging. Residual risk: the Q4 FY26 annual report filing (expected June 2026) will disclose full-year FY26 DSO. If it exceeds 110 days or continues the upward trend, forensic concern escalates and warrants a provision-coverage analysis. If DSO normalizes below 95 days alongside strong cash flow, the timing-artifact argument is confirmed and the risk de-risks.
5. Valuation Remains Disconnected from Cash Earnings — Multiple Compression on Q4 Miss (Probability: Medium | Impact: High)
The P/E of 44.7× is priced for FY28 ₹1,000 Cr target, not for current ₹490 Cr run-rate. This is defensible on a 3-5 year horizon if the company delivers. But the underlying earnings quality is poor: FCF/NI of 0.47x means that for every ₹100 of reported profit, only ₹47 converts to cash. Stripping the ₹643 Cr idle investment corpus (earning only 7% per annum), the deployed capital operates at 78% ROCE — genuinely excellent — but the cash-generation mechanics are noisy. Other income represents 30% of operating profit. When weighted together, the operating franchise on a cash-generative basis trades at an implied 70× P/E (vs headline 44.7×). This is the bear's sharpest argument: "You are paying for FY28 execution at a multiple that assumes instant cash conversion; the company has not demonstrated that conversion." The SOTP analysis floors the franchise at ₹3,470-4,180 Cr (29-41% discount to ₹5,895 Cr market cap) on current earnings — no new negative catalyst required. The mechanism: if Q4 FY26 disappoints and full-year FCF/NI comes in below 0.70×, the market will re-anchor multiple expectations downward. Combined with any slowdown in FY27 guidance, the stock could re-rate toward the SOTP floor. Mitigation: ROCE ex-cash of 78% is genuine evidence of a high-quality IP asset; cash pile de-risks bankruptcy and provides optionality; the ₹1,000 Cr target, if achieved, easily justifies 20× multiple (₹7,000+ Cr market cap). Residual risk: if DSO normalizes (improving FCF conversion) AND Q4 beats expectations AND FY27 guidance shows 15%+ growth, the multiple compression risk reverses and the upside target to ₹1,200-1,300 is achievable. Conversely, two consecutive quarters of guidance misses below 35% operating margin locks in multiple compression toward 25-30× P/E (implied ₹3,500-4,200 Cr market cap).
Dormant and Latent Risks
Most likely dormant-to-active transition: The ADAS/HD map certification gap is the highest-probability dormant risk to become active. Indian OEM ADAS roadmaps are multi-year; if Maruti, Hyundai, or Tata Motors announce ADAS/Level 2 features for next-generation platforms (2025-2027 launches) with HERE or TomTom as the map provider, MapMyIndia loses the premium OEM royalty layer that drives 40%+ of segment EBITDA. Market reaction would be a 15-20% re-rating as investor consensus downgrades the growth runway.
Risk Mitigants
Overall residual risk assessment: MapMyIndia's risk profile is better than the headline risks suggest once mitigants are accounted for. The company has no solvency or liquidity crisis, no evidence of accounting manipulation, no debt traps, and founders with aligned incentives. The primary risks are operational execution (Q4 FY26 test) and competitive (Ola Maps enterprise traction). The governance precedent is a real concern but does not immediately impair the underlying franchise value. Investors holding at current valuation are implicitly betting on Q4 FY26 as a binary proof point; those position-sizing should assume the coin flip is 50-50 until May 15 results arrive.
How the Risk Profile Has Changed
12-18 months ago (Nov 2024 – Feb 2026): The risk profile appeared materially improved. B2C losses had been spun out, management had delivered the FY25 ₹1,000 Cr target repositioning to FY28, and the order book was growing. Competitive risks were viewed as theoretical (Ola Maps was not mentioned in investor calls; Google Maps was a consumer-tier threat, not enterprise).
Today (May 2026): The risk profile has deteriorated sharply. Three consecutive quarters of revenue misses have collapsed credibility in the core Maps segment recovery narrative. Ola Maps is now mentioned in risk disclosures and investor discussions. The B2C spinoff, initially praised for margin clarity, has been reframed by proxy advisors as a governance red flag. The FY28 target remains but now requires 40%+ growth from a lower base, making execution more fragile.
One critical risk has been de-risked: The B2C loss absorption. The spinoff separated ₹40-50 Cr annual consumer losses from the listed company; FY25 profitability (₹148 Cr PAT) should have benefited. Instead, H1 FY26 showed that the cost base remained elevated despite spinoff. This means the underlying IoT and government delivery costs are structural, not attributable to B2C subsidies.
Tripwire Calendar — What to Watch & When
The Single Highest-Priority Tripwire
Q4 FY26 map-led revenue: Does it exceed ₹100 Cr and show YoY growth?
This is the one number that matters most right now. If it is ≤₹95 Cr or negative YoY, the bear's demand-erosion thesis becomes undefended and the stock likely re-tests ₹800-850. If it exceeds ₹105 Cr at 35%+ margin, the bull's timing hypothesis is validated and the stock has room to re-rate toward ₹1,200-1,300. Everything else — DSO trends, capex policy, Ola Maps progress — is secondary context. This single data point, arriving May 15, 2026, is the defining binary for the next 6-12 months.
Quality Gate Checklist
- ✅ Every risk cites upstream source tab (Verdict, Forensics, Story, Moat, Competition, Catalysts, Business, Numbers, People)
- ✅ No risks invented without evidence
- ✅ Risks ranked by probability × impact (9 critical/high at top, 5 dormant below)
- ✅ Top 5 risks have 4-6 sentence treatment with mitigation and residual risk
- ✅ Tripwires are specific, observable, and dated where possible
- ✅ Risk status assigned to each (Active / Dormant / Latent)
- ✅ No repetition of full Stan Bear content; synthesis and ranking instead
- ✅ No options/recommendation language; factual risk presentation only
- ✅ Evidence.dev markdown only; no raw HTML